Stumpf A D, Hoffmann C
Bio-Imaging Center, Rudolf-Virchow-Zentrum für Experimentelle Medizin, University of Würzburg, Würzburg, Germany.
Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.
Br J Pharmacol. 2016 Jan;173(2):255-66. doi: 10.1111/bph.13382. Epub 2015 Dec 19.
In 2003, the first report was published that presented proof of principle for a novel class of FRET biosensors for use in living cells. This novel sensor class was built on the base of GPCRs, which represent an integral transmembrane receptor family passing the membrane seven times and are thus also called the 7TM receptor family. As an estimated number of 30% of all marketed drugs exert their effects by modulating GPCR function, these initial reports promised the gain of novel insights into receptor function. Such FRET sensors have slowly, but progressively, made their way into the standard toolbox for GPCR research as several groups are now reporting on the generation and use of these sensors. By now, FRET sensors have been reported for 18 different GPCRs, and more are expected to be added. These particular receptor sensors have been used to investigate receptor dynamics in living cells to evaluate ligand binding and ligand efficacy in real time, to study voltage and mechanosensitivity of GPCRs or to study the influence of receptor polymorphisms on receptor function in real-time. In this review we will describe the different design principles of these GPCR-based sensors and will summarize their current biological applications in living cells.
2003年,首篇报告发表,展示了一类用于活细胞的新型荧光共振能量转移(FRET)生物传感器的原理证明。这类新型传感器基于G蛋白偶联受体(GPCR)构建,GPCR是一类完整的跨膜受体家族,其跨膜七次,因此也被称为七次跨膜受体家族。据估计,所有上市药物中有30%是通过调节GPCR功能发挥作用的,这些最初的报告有望为受体功能带来新的见解。这类FRET传感器已缓慢但逐步地进入GPCR研究的标准工具箱,因为现在有几个研究小组报告了这些传感器的产生和应用。到目前为止,已报道了针对18种不同GPCR的FRET传感器,预计还会增加更多。这些特定的受体传感器已被用于研究活细胞中的受体动力学,以实时评估配体结合和配体效力,研究GPCR的电压和机械敏感性,或实时研究受体多态性对受体功能的影响。在本综述中,我们将描述这些基于GPCR的传感器的不同设计原理,并总结它们目前在活细胞中的生物学应用。